Skip to content
Home/Companies/Biotech/Isarna Therapeutics
IT

Isarna Therapeutics

Biotech·Germany·Active·21yr hold

Isarna Therapeutics is a biotech company, headquartered in Germany.

Entry
2005
Hold
21yr
Status
Active
Est. EV
–

Who owns Isarna Therapeutics?

Isarna Therapeutics is currently owned by MIG Capital through MIG Fonds 5 (2007 vintage), since 2005.

Hand-verified · updated 2026-07-03

MIG Capital
Investor
MIG Capital
MIG Fonds 5 · 2007 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from MIG Fonds 5

Other portfolio companies in the same fund.

advanceCOR
Active
BiotechGermany· 2012
Immatics
Active
BiotechGermany· 2010
AmSilk
Active
BiotechGermany· 2008
instrAction
Active
Deep TechGermany· 2008
OD-OS
Active
MedTechGermany· 2008
Ganymed Pharmaceuticals
Exited 2016
BiotechGermany· 2007
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings